13F HOLDINGS REPORT
Propel Bio Management, LLC
Quarter ended Q2 2024 · Filed August 12, 2024 · Accession 0001829126-24-005385
Total Value
$154.2M
Positions
25
Other Managers
1
Confidential Omitted
No
Holdings (25)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | APPLIED THERAPEUTICS INC | 03828A101 | 6,567,858 | $30.7M | 19.89% |
| 2 | PLAINS GP HOLDINGS LP-CL | PAGP | 1,372,360 | $25.8M | 16.75% |
| 3 | TSCAN THERAPEUTICS INC | TCRX | 2,087,139 | $12.2M | 7.92% |
| 4 | MADRIGAL PHARMACEUTICALS | MDGL | 43,032 | $12.1M | 7.82% |
| 5 | ACHIEVE LIFE SCIENCES INC | ACHV | 2,453,092 | $11.5M | 7.48% |
| 6 | PHATHOM PHARMACEUTICALS I | PHAT | 869,927 | $9.0M | 5.81% |
| 7 | AKERO THERAPEUTICS INC | 00973Y108 | 327,752 | $7.7M | 4.99% |
| 8 | AVIDITY BIOSCIENCES INC | 05370A108 | 178,500 | $7.3M | 4.73% |
| 9 | ARDELYX INC | ARDX | 924,583 | $6.9M | 4.44% |
| 10 | FULCRUM THERAPEUTICS INC | FULC | 750,000 | $4.7M | 3.02% |
| 11 | ATHIRA PHARMA INC | 04746L104 | 1,492,792 | $4.0M | 2.57% |
| 12 | TELESAT CORP | TSAT | 365,781 | $3.3M | 2.16% |
| 13 | VERRICA PHARMACEUTICALS I | VRCA | 424,937 | $3.1M | 2.01% |
| 14 | KURA ONCOLOGY INC | KURA | 130,000 | $2.7M | 1.74% |
| 15 | ABEONA THERAPEUTICS INC | ABEO | 624,022 | $2.6M | 1.72% |
| 16 | ABEONA THERAPEUTICS INC | ABEO | 624,022 | $2.6M | 1.72% |
| 17 | EIGER BIOPHARMACEUTICALS | 28249U204 | 146,381 | $1.9M | 1.20% |
| 18 | SYNDAX PHARMACEUTICALS IN | SNDX | 83,259 | $1.7M | 1.11% |
| 19 | KYMERA THERAPEUTICS INC | KYMR | 56,359 | $1.7M | 1.09% |
| 20 | KAYNE ANDERSON ENERGY INF | 486606106 | 147,033 | $1.5M | 0.99% |
| 21 | TREVI THERAPEUTICS INC | TRVI | 260,000 | $774,800 | 0.50% |
| 22 | FIDELITY INV MMTRSY 1 680 | X9USDFIDT | 317,014 | $317,014 | 0.21% |
| 23 | CYBIN INC | HELP | 850,000 | $230,350 | 0.15% |
| 24 | MAAT PHARMA SACA | 00BNRR5C1 | 1,362 | $9,752 | 0.01% |
| 25 | CHINOOK THERAPEUTICS | 169CVR016 | 79,357 | $9,750 | 0.01% |